Injection of 4T1 breast cancer cells into 40-week-old BALB/c mice also increased fibronectin deposition, a known store for EndMT inducer transforming growth factor β (TGFβ) (Ma et al., 2020) (Figure 10E). The gene discussed is TGFB1; the disease is breast carcinoma.